Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros











Tipo de estudio
Intervalo de año de publicación
1.
Mem. Inst. Oswaldo Cruz ; 109(8): 1050-1056, 12/2014. tab, graf
Artículo en Inglés | LILACS | ID: lil-732611

RESUMEN

This study is the first phytochemical investigation of Selaginella sellowii and demonstrates the antileishmanial activity of the hydroethanolic extract from this plant (SSHE), as well as of the biflavonoids amentoflavone and robustaflavone, isolated from this species. The effects of these substances were evaluated on intracellular amastigotes of Leishmania (Leishmania) amazonensis, an aetiological agent of American cutaneous leishmaniasis. SSHE was highly active against intracellular amastigotes [the half maximum inhibitory concentration (IC50) = 20.2 µg/mL]. Fractionation of the extract led to the isolation of the two bioflavonoids with the highest activity: amentoflavone, which was about 200 times more active (IC50 = 0.1 μg/mL) and less cytotoxic than SSHE (IC50 = 2.2 and 3 μg/mL, respectively on NIH/3T3 and J774.A1 cells), with a high selectivity index (SI) (22 and 30), robustaflavone, which was also active against L. amazonensis (IC50 = 2.8 µg/mL), but more cytotoxic, with IC50 = 25.5 µg/mL (SI = 9.1) on NIH/3T3 cells and IC50 = 3.1 µg/mL (SI = 1.1) on J774.A1 cells. The production of nitric oxide (NO) was lower in cells treated with amentoflavone (suggesting that NO does not contribute to the leishmanicidal mechanism in this case), while NO release was higher after treatment with robustaflavone. S. sellowii may be a potential source of biflavonoids that could provide promising compounds for the treatment of cutaneous leishmaniasis.


Asunto(s)
Animales , Femenino , Ratones , Antiprotozoarios/uso terapéutico , Biflavonoides/uso terapéutico , Leishmania/efectos de los fármacos , Leishmaniasis Cutánea/tratamiento farmacológico , Fitoterapia , Extractos Vegetales/uso terapéutico , Selaginellaceae/química , Biflavonoides/aislamiento & purificación , Leishmania/metabolismo , Ratones Endogámicos BALB C , Pruebas de Sensibilidad Microbiana , Macrófagos/efectos de los fármacos , Óxido Nítrico/análisis , Cultivo Primario de Células
2.
Mem Inst Oswaldo Cruz ; 109(8): 1050-6, 2014 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-25591109

RESUMEN

This study is the first phytochemical investigation of Selaginella sellowii and demonstrates the antileishmanial activity of the hydroethanolic extract from this plant (SSHE), as well as of the biflavonoids amentoflavone and robustaflavone, isolated from this species. The effects of these substances were evaluated on intracellular amastigotes of Leishmania (Leishmania) amazonensis, an aetiological agent of American cutaneous leishmaniasis. SSHE was highly active against intracellular amastigotes [the half maximum inhibitory concentration (IC50) = 20.2 µg/mL]. Fractionation of the extract led to the isolation of the two bioflavonoids with the highest activity: amentoflavone, which was about 200 times more active (IC50 = 0.1 µg/mL) and less cytotoxic than SSHE (IC50 = 2.2 and 3 µg/mL, respectively on NIH/3T3 and J774.A1 cells), with a high selectivity index (SI) (22 and 30), robustaflavone, which was also active against L. amazonensis (IC50 = 2.8 µg/mL), but more cytotoxic, with IC50 = 25.5 µg/mL (SI = 9.1) on NIH/3T3 cells and IC50 = 3.1 µg/mL (SI = 1.1) on J774.A1 cells. The production of nitric oxide (NO) was lower in cells treated with amentoflavone (suggesting that NO does not contribute to the leishmanicidal mechanism in this case), while NO release was higher after treatment with robustaflavone. S. sellowii may be a potential source of biflavonoids that could provide promising compounds for the treatment of cutaneous leishmaniasis.


Asunto(s)
Antiprotozoarios/uso terapéutico , Biflavonoides/uso terapéutico , Leishmania/efectos de los fármacos , Leishmaniasis Cutánea/tratamiento farmacológico , Fitoterapia , Extractos Vegetales/uso terapéutico , Selaginellaceae/química , Animales , Biflavonoides/aislamiento & purificación , Femenino , Leishmania/metabolismo , Macrófagos/efectos de los fármacos , Ratones , Ratones Endogámicos BALB C , Pruebas de Sensibilidad Microbiana , Células 3T3 NIH , Óxido Nítrico/análisis , Cultivo Primario de Células
3.
Brain Res ; 1369: 167-72, 2011 Jan 19.
Artículo en Inglés | MEDLINE | ID: mdl-20977896

RESUMEN

Status epilepticus-induced hippocampal neuronal loss is mainly associated with excitotoxicity induced by increased levels of extracellular glutamate which is normally neutralized by high-affinity uptake mechanism. The energy source for the glutamate uptake is the electrochemical Na(+) gradient maintained by Na(+)/K(+) ATPase pump. In this study, we investigated the effect of early-life-induced status epilepticus on hippocampal Na(+)/K(+) ATPase activity and glutamate uptake. Rat pups 15 days old were injected i.p. with LiCl (3 mEq/kg) 12-18 h prior to s.c. pilocarpine administration (60 mg/kg). Hippocampal Na(+)/K(+) ATPase activity and glutamate uptake were evaluated 1.5, 12 and 24 h after SE induction. LiCl-pilocarpine-induced SE decreased Na(+)/K(+) ATPase activity and glutamate uptake by 42 and 38%, respectively, 1.5 h after SE induction. However, 12 and 24 h after SE induction the pump activity and glutamate uptake returned to control levels. SE early in life increased hippocampal number of degenerating neurons in the CA1 subfield and dentate gyrus 24 h after SE induction. In conclusion, SE induced early in life causes short-term disruption in hippocampal Na(+)/K(+) ATPase activity and glutamate uptake, which may be related to neuronal death found in CA1 subfield.


Asunto(s)
Ácido Glutámico/metabolismo , Hipocampo/metabolismo , ATPasa Intercambiadora de Sodio-Potasio/metabolismo , Estado Epiléptico/metabolismo , Animales , Convulsivantes/toxicidad , Activación Enzimática/efectos de los fármacos , Hipocampo/efectos de los fármacos , Hipocampo/patología , Cloruro de Litio/toxicidad , Masculino , Degeneración Nerviosa/metabolismo , Degeneración Nerviosa/patología , Pilocarpina/toxicidad , Ratas , Ratas Wistar , Estado Epiléptico/inducido químicamente , Estado Epiléptico/patología
4.
Epilepsia ; 49(5): 842-52, 2008 May.
Artículo en Inglés | MEDLINE | ID: mdl-18177363

RESUMEN

PURPOSE: This study investigated putative correlations among behavioral changes and: (1) neuronal loss, (2) hippocampal mossy fiber sprouting, and (3) reactive astrogliosis in adult rats submitted to early-life LiCl-pilocarpine-induced status epilepticus (SE). METHODS: Rats (P15) received LiCl (3 mEq/kg, i.p.) 12-18 h prior pilocarpine (60 mg/kg; s.c.). At adulthood, animals were submitted to behavioral tasks and after the completion of tasks biochemical and histological analysis were performed. RESULTS: In SE group, it was observed an increased number of degenerating neurons in the CA1 subfield and in the hilus of animals 24 h after SE. At adulthood, SE group presented an aversive memory deficit in an inhibitory avoidance task and the animals that presented lower latency to the step down showed a higher score for mossy fiber sprouting. In the light-dark exploration task, SE rats returned less and spent less time in the light compartment and present an increased number of risk assessment behavior (RA). There was a negative correlation between the time spent in the light compartment and the score for mossy fiber sprouting and a positive correlation between score for mossy fiber sprouting and number of RA. LiCl-pilocarpine-treated animals showed higher levels of S100B immunocontent in the CSF as well as a positive correlation between the score for sprouting and the GFAP immunocontent in the CA1 subfield, suggesting an astrocytic response to neuronal injury. CONCLUSIONS: We showed that LiCl-pilocarpine-induced SE during development produced long-lasting behavioral abnormalities, which might be associated with mossy fiber sprouting and elevated CSF S100B levels at adulthood.


Asunto(s)
Estado Epiléptico/inducido químicamente , Factores de Edad , Animales , Animales Recién Nacidos/crecimiento & desarrollo , Ansiedad/inducido químicamente , Conducta Animal/efectos de los fármacos , Conducta Animal/fisiología , Miedo/efectos de los fármacos , Miedo/psicología , Hipocampo/efectos de los fármacos , Hipocampo/patología , Cloruro de Litio/farmacología , Memoria/efectos de los fármacos , Memoria/fisiología , Fibras Musgosas del Hipocampo/efectos de los fármacos , Fibras Musgosas del Hipocampo/fisiopatología , Factores de Crecimiento Nervioso/sangre , Pilocarpina/farmacología , Ratas , Ratas Wistar , Subunidad beta de la Proteína de Unión al Calcio S100 , Proteínas S100/sangre , Estado Epiléptico/sangre , Estado Epiléptico/fisiopatología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA